Steven M Greenberg is an expert in Neurology at Massachusetts General Hospital (United States). As of October 2026, ScienceLeadR ranks Steven M Greenberg in the top 1% of experts worldwide for Cerebral Hemorrhage, Proteostasis Deficiencies and Cerebrovascular Disorders. Steven M Greenberg has authored 845 publications, the most recent in 2026, and is an investigator in 15 clinical trials, 1 of them ongoing. SLR score: 3,941 (community average: 125). How the SLR is computed.

LeadR Profile

Steven M Greenberg Massachusetts General Hospital United States
3 941 ScienceLeadR Reputation 3941
Network Map

Neurology

Subspecialties: Cardiology - Psychiatry - Hematology

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Organizations

Career arc: 1988 - 2026

Source: PubMed

Massachusetts General Hospital

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 845

Citations

Citations: 78 336 1st author: 59 Last author: 138 Unique author: 18


Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Centrum Semiovale Perivascular Spaces Predict First Hemorrhagic Lesion in Asymptomatic Amyloid-Positive Individuals.
PMID 42855813 — hemorrhage, cognitive dysfunction, basal ganglia, amyloid, wounds and injuries, ganglia
Ann Neurol20260
Amyloid-Related Imaging Abnormalities Summit Special Proceedings: Cardiovascular and Stroke Considerations for β-Amyloid Immunotherapy in Alzheimer Disease.
PMID 42622140 — heart diseases, stroke, emergencies, alzheimer disease, cognitive dysfunction, immunotherapy, cognition disorders, risk factors, therapeutics, amyloid, heart disease risk factors
J Am Heart Assoc20260
Spatiotemporal Associations Between Cortical Microinfarcts and Cortical Superficial Siderosis in Cerebral Amyloid Angiopathy.
PMID 42385122 — hemorrhage, siderosis, amyloid, wounds and injuries, cerebral amyloid angiopathy, neurology
Neurology20262
Cognitive decline in Dutch-type hereditary and sporadic cerebral amyloid angiopathy: a 5-year follow-up study.
PMID 42360287 — dementia, hemorrhage, follow-up studies, alzheimer disease, executive function, cognitive dysfunction, cognition disorders, amyloid, cerebral amyloid angiopathy, cognition
Alzheimers Dement20260
Long-Term Blood Pressure Variability in Cerebral Amyloid Angiopathy is Associated with Ischemic Brain Injury and Cognitive Decline.
PMID 42294770 — white matter, hypertension, brain injuries, heart diseases, blood, neurobehavioral manifestations, stroke, brain, blood pressure, cognitive dysfunction, signs and symptoms, cognition disorders, risk factors, amyloid, memory, cerebral amyloid angiopathy
J Am Heart Assoc20260

Clinical Studies 15

Sources: ClinicalTrials, EU CTIS

Synthesis

Principal Investigator: 2

By phase:

Phase 3 7
N/A 5
Phase 2 3

By status:

Completed 9
Active not recruiting 3
Terminated 3

By type:

Interventional 12
Observational 3

By Monocentric/Multicentric:

monocentric 4
multicentric2to4 1
multicentric5to9 2
multicentricup10 8

Main Topics

Cohort/Consortium Investigators 3

Ongoing Clinical Trials

Ongoing trial started since 2021, where this expert is an investigator

Source: ClinicalTrials

Study Phase Status Start
Biomarkers for Vascular Contributions to Cognitive Impairment and Dementia Consortium
NCT06284213 — dementia, blood, brain, cognitive dysfunction, biomarkers, cognition disorders, research, memory
N/AActive not recruiting2021

LeadR Networks

Main global connection map